Paulson & Co’s Insmed INSM Stock Holding History

Paulson & Co’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-90,000	Closed	-$1.58M	–	115
2017 Q1	$1.58M	Sell	90,000 -115,200	-56%	-$1.78M	0.02%	86
2016 Q4	$2.71M	Hold	205,200	–	–	0.03%	82
2016 Q3	$2.98M	Hold	205,200	–	–	0.03%	80
2016 Q2	$2.02M	Hold	205,200	–	–	0.02%	75
2016 Q1	$2.6M	Buy	205,200 +40,000	+24%	+$526K	0.02%	78
2015 Q4	$3M	Buy	+165,200	New	+$2.91M	0.02%	64

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Paulson & Co's INSM Position: Q2 2017 in Review

Paulson & Co sold out of Insmed (INSM) in Q2 2017, closing a stake of 90,000 shares — an estimated $1.58M sold.

Paulson & Co first reported a position in INSM in Q4 2015 and held it in 6 quarters. The position peaked at $3M in Q4 2015. 114 funds tracked by Wall St. Rank hold INSM as of Q2 2017.

Paulson & Co reported no remaining Insmed position as of Q2 2017 after selling out during the quarter.
Paulson & Co sold 90,000 Insmed shares in Q2 2017, an estimated $1.58M.
Paulson & Co first reported a position in Insmed in Q4 2015 and held it in 6 quarters.
Paulson & Co's Insmed position peaked at $3M in Q4 2015.
114 funds tracked by Wall St. Rank held Insmed as of Q2 2017.

Based on Paulson & Co's 13F filing for Q2 2017, filed 14 Aug 2017.